Allergy Therapeutics Plc – Strategy, SWOT and Corporate Finance Report

Allergy Therapeutics Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alternative of aluminium to develop aluminium-free immunotherapy vaccines. Allergy Therapeutics product portfolio includes Pollinex Grasses + Rye and Pollinex Trees vaccines. It also offers allergen extracts used for skin prick testing. The company’s diagnostics products comprise of Pollen, Moulds, Arthropods, Epithelia and others. It has operational presence in Germany, Italy, Spain, Austria, Switzerland, Slovakia, Czech Republic, the Netherlands and the UK. Allergy Therapeutics is headquartered in Worthing, West Sussex, the UK.

Scope

Detailed information on Allergy Therapeutics Plc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Allergy Therapeutics Plc in the form of a SWOT analysis

An in-depth view of the business model of Allergy Therapeutics Plc including a breakdown and examination of key business segments

News about Allergy Therapeutics Plc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Allergy Therapeutics Plc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Allergy Therapeutics Plc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Allergy Therapeutics Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Stallergenes Greer plc

Sanofi UK

Roxall Medizin GmbH

Laboratorios LETI SL

HAL Allergy BV

Circassia Pharmaceuticals Plc

Biomay AG

Allergopharma GmbH & Co KG

ALK-Abello Ltd

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Allergy Therapeutics Plc - Key Facts 6

Allergy Therapeutics Plc - Key Employees 7

Allergy Therapeutics Plc - Key Employee Biographies 8

Allergy Therapeutics Plc - Key Operational Employees 9

Allergy Therapeutics Plc - Major Products and Services 10

Allergy Therapeutics Plc - History 11

Allergy Therapeutics Plc - Company Statement 13

Allergy Therapeutics Plc - Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2 Company Analysis 16

Company Overview 16

Allergy Therapeutics Plc - Business Description 17

Allergy Therapeutics Plc - Corporate Strategy 18

Allergy Therapeutics Plc - SWOT Analysis 19

SWOT Analysis - Overview 19

Allergy Therapeutics Plc - Strengths 19

Allergy Therapeutics Plc - Weaknesses 20

Allergy Therapeutics Plc - Opportunities 21

Allergy Therapeutics Plc - Threats 22

Allergy Therapeutics Plc - Key Competitors 23

Section 3 Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios - Interim Ratios 29

Financial Ratios - Ratio Charts 30

Section 4 Company’s Lifesciences Financial Deals and Alliances 31

Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Allergy Therapeutics Plc, Recent Deals Summary 33

Section 5 Company’s Recent Developments 34

Sep 26, 2018: Allergy Therapeutics announces preliminary results for the year ended 30 June 2018 34

Jul 12, 2018: Allergy Therapeutics: Trading Update 39

May 14, 2018: Allergy Therapeutics Publishes New Data Validating Mode of Action and Unique Adjuvant Properties of its Patented Adjuvant, Microcrystalline Tyrosine (MCT®), in The Journal of Immunology 40

Mar 07, 2018: Allergy Therapeutics: Interim Results for the six months ended 31 December 2017 41

Feb 02, 2018: Allergy Therapeutics Announces Corporate Update 44

Jan 31, 2018: Allergy Therapeutics: Trading Update 46

Sep 28, 2017: Allergy Therapeutics: Preliminary Results 47

Sep 11, 2017: Allergy Therapeutics: Expansion of Clinical Development and R&D teams 52

Jun 06, 2017: Allergy Therapeutics: Directorate changes 53

Mar 29, 2017: Allergy Therapeutics: Interim Results for the six months ended 31 December 2016 54

Section 6 Appendix 55

Methodology 55

Ratio Definitions 55

About GlobalData 59

Contact Us 59

Disclaimer 59

List of Tables

List of Tables

Allergy Therapeutics Plc, Key Facts 6

Allergy Therapeutics Plc, Key Employees 7

Allergy Therapeutics Plc, Key Employee Biographies 8

Allergy Therapeutics Plc, Key Operational Employees 9

Allergy Therapeutics Plc, Major Products and Services 10

Allergy Therapeutics Plc, History 11

Allergy Therapeutics Plc, Subsidiaries 14

Allergy Therapeutics Plc, Key Competitors 23

Allergy Therapeutics Plc, Ratios based on current share price 24

Allergy Therapeutics Plc, Annual Ratios 25

Allergy Therapeutics Plc, Annual Ratios (Cont…1) 26

Allergy Therapeutics Plc, Annual Ratios (Cont…2) 27

Allergy Therapeutics Plc, Interim Ratios 29

Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Allergy Therapeutics Plc, Recent Deals Summary 33

Currency Codes 55

Capital Market Ratios 55

Equity Ratios 56

Profitability Ratios 56

Cost Ratios 57

Liquidity Ratios 57

Leverage Ratios 58

Efficiency Ratios 58

List of Figures

List of Figures

Allergy Therapeutics Plc, Performance Chart (2014 – 2018) 28

Allergy Therapeutics Plc, Ratio Charts 30

Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports